rs1064794189
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_004655.4(AXIN2):c.1206_1208delAGA(p.Glu403del) variant causes a disruptive inframe deletion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. E402E) has been classified as Likely benign.
Frequency
Consequence
NM_004655.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- oligodontia-cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- craniosynostosisInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AXIN2 | ENST00000307078.10 | c.1206_1208delAGA | p.Glu403del | disruptive_inframe_deletion | Exon 6 of 11 | 1 | NM_004655.4 | ENSP00000302625.5 | ||
| AXIN2 | ENST00000375702.5 | c.1206_1208delAGA | p.Glu403del | disruptive_inframe_deletion | Exon 5 of 9 | 1 | ENSP00000364854.5 | |||
| AXIN2 | ENST00000618960.4 | c.1206_1208delAGA | p.Glu403del | disruptive_inframe_deletion | Exon 6 of 10 | 5 | ENSP00000478916.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Oligodontia-cancer predisposition syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 419927). This variant has not been reported in the literature in individuals affected with AXIN2-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.1206_1208del, results in the deletion of 1 amino acid(s) of the AXIN2 protein (p.Glu403del), but otherwise preserves the integrity of the reading frame. -
not provided Uncertain:1
This in-frame deletion of 3 nucleotides in AXIN2 is denoted c.1206_1208delAGA at the cDNA level and p.Glu403del (E403del) at the protein level. The normal sequence, with the bases that are deleted in braces, is ATGA[AGA]GAGA. This deletion of a single Glutamic Acid residue occurs at a position that is not conserved across species and is located in the GSK3-beta binding domain (Hughes 2007). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. Since in-frame deletions may or may not inhibit proper protein functioning, the clinical significance of this finding remains unclear at this time and we consider AXIN2 Glu403del to be a variant of uncertain significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.1206_1208delAGA variant (also known as p.E403del) is located in coding exon 5 of the AXIN2 gene. This variant results from an in-frame AGA deletion at nucleotide positions 1206 to 1208. This results in the in-frame deletion of a glutamic acid at codon 403. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at